BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12046998)

  • 1. Evaluation of the effectiveness of UK community pharmacists' interventions in community palliative care.
    Needham DS; Wong IC; Campion PD;
    Palliat Med; 2002 May; 16(3):219-25. PubMed ID: 12046998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of community pharmacists in providing clinical medication reviews.
    Laaksonen R; Duggan C; Bates I
    Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication management for community palliative care patients and the role of a specialist palliative care pharmacist: A qualitative exploration of consumer and health care professional perspectives.
    Kuruvilla L; Weeks G; Eastman P; George J
    Palliat Med; 2018 Sep; 32(8):1369-1377. PubMed ID: 29793391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do patients with cancer pain view community pharmacy services? An interview study.
    Edwards Z; Blenkinsopp A; Ziegler L; Bennett MI
    Health Soc Care Community; 2018 Jul; 26(4):507-518. PubMed ID: 29479766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncology pharmacist as part of the palliative treatment team.
    Crul M; Oosterhof P
    Int J Pharm Pract; 2020 Feb; 28(1):92-96. PubMed ID: 31576620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of pharmacists' integration into patient-centered medical home teams.
    Patterson BJ; Solimeo SL; Stewart KR; Rosenthal GE; Kaboli PJ; Lund BC
    Res Social Adm Pharm; 2015; 11(1):85-95. PubMed ID: 24954185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).
    Tan EC; Stewart K; Elliott RA; George J
    Res Social Adm Pharm; 2014; 10(4):623-32. PubMed ID: 24095088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supporting patient access to medicines in community palliative care: on-line survey of health professionals' practice, perceived effectiveness and influencing factors.
    Latter S; Campling N; Birtwistle J; Richardson A; Bennett MI; Ewings S; Meads D; Santer M
    BMC Palliat Care; 2020 Sep; 19(1):148. PubMed ID: 32972414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frail older people with multi-morbidities in primary care: a new integrated care clinical pharmacy service.
    Oboh L; Leon C; Qadir S; Smith F; Francis SA
    Int J Clin Pharm; 2018 Feb; 40(1):41-47. PubMed ID: 29222733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of pharmacist in community palliative care-a scoping review.
    Thrimawithana TR; Spence M; Lee M; Naysoe N; Hanna S; Yako G; Goma S; Stupans I; Lim CX
    Int J Pharm Pract; 2024 May; 32(3):194-200. PubMed ID: 38584472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacists' medicines-related interventions for people with intellectual disabilities: a narrative review.
    O'Dwyer M; Meštrović A; Henman M
    Int J Clin Pharm; 2015 Aug; 37(4):566-78. PubMed ID: 25903938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical nurse specialists in palliative care. Part 1. A description of the MacMillan Nurse caseload.
    Skilbeck J; Corner J; Bath P; Beech N; Clark D; Hughes P; Douglas HR; Halliday D; Haviland J; Marples R; Normand C; Seymour J; Webb T
    Palliat Med; 2002 Jul; 16(4):285-96. PubMed ID: 12132541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of palliative care team pharmacists in designated cancer hospitals: a nationwide survey in Japan.
    Ise Y; Morita T; Katayama S; Kizawa Y
    J Pain Symptom Manage; 2014 Mar; 47(3):588-93. PubMed ID: 24018207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current and future roles of community pharmacists: views and experiences of patients with type 2 diabetes.
    Twigg MJ; Poland F; Bhattacharya D; Desborough JA; Wright DJ
    Res Social Adm Pharm; 2013; 9(6):777-89. PubMed ID: 23127392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of clinical pharmacists' follow-up service in an oncology pain clinic.
    Ryan N; Chambers C; Ralph C; England D; Cusano F
    J Oncol Pharm Pract; 2013 Jun; 19(2):151-8. PubMed ID: 23019117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of pharmaceutical expertise in a palliative care team in Sweden.
    Norrström B; Cannerfelt IB; Frid H; Roos K; Ramström H
    Pharm World Sci; 2010 Dec; 32(6):829-34. PubMed ID: 21052836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists' performance of clinical interventions during adherence support medication reviews.
    Hatah E; Tordoff J; Duffull SB; Braund R
    Res Social Adm Pharm; 2014; 10(1):185-94. PubMed ID: 23688540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the community pharmacy in palliative care: a nationwide survey in Japan.
    Ise Y; Morita T; Maehori N; Kutsuwa M; Shiokawa M; Kizawa Y
    J Palliat Med; 2010 Jun; 13(6):733-7. PubMed ID: 20597706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The palliative care interdisciplinary team: where is the community pharmacist?
    O'Connor M; Pugh J; Jiwa M; Hughes J; Fisher C
    J Palliat Med; 2011 Jan; 14(1):7-11. PubMed ID: 21244249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.